Mankind Pharma (MANKIND) Share Price Falls 2.73% as Large Cap Stock Trades Lower

Mankind Pharma Share Price traded at Rs 2,475.50 in today’s session, down 2.73% from the previous close of Rs 2,545. The stock’s market capitalisation stood at Rs 1,00,764.41 crore, keeping Mankind Pharma in the Large Cap category. The verified data confirms a price fall, but it does not establish a company-specific trigger. For readers following Mankind Pharma Share Price Today, the key point is the session decline and the scale of the company, not a fresh business update.

Mankind Pharma Share Price opened at Rs 2,545, matched the previous close, and then moved within a range of Rs 2,460 to Rs 2,554.75. That left the stock Rs 69.50 below the prior close by the latest reading. The move is best read as a single-session decline within a large listed healthcare name. Univest is tracking the price action as part of Mankind Pharma Stock News and broader market monitoring.

Mankind Pharma (MANKIND) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,475.5
Previous Close	Rs 2,545
Today's Move	-Rs 69.50 (-2.73%)
Open	Rs 2,545
High	Rs 2,554.75
Low	Rs 2,460
Market Capitalisation	Rs 1,00,764.41 crore
Market Cap Category	Large Cap

Mankind Pharma Share Price opened flat versus the previous close and then moved lower through the session. The high of Rs 2,554.75 and the low of Rs 2,460 show a defined intraday band, but the available data does not point to a single verified catalyst. For those tracking Mankind Pharma Share Price Today, the move is meaningful because it combines a clear percentage decline with a large market capitalisation. The company remains a large listed healthcare name, so even a one-session decline tends to attract attention.

Mankind Pharma (MANKIND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,00,764.41 crore
P/E Ratio	51.46x
P/B Ratio	6.25x
ROE	12.69%
ROCE	13.24%
EPS	Rs 49.45
Book Value Per Share	Rs 407.39
Dividend Yield	0.04%

Mankind Pharma Share Price is backed by EPS of Rs 49.45, book value per share of Rs 407.39 and a dividend yield of 0.04%. The company trades at a P/E of 51.46 and a P/B of 6.25, which shows that the market values it above accounting net worth and at a premium earnings multiple. ROE is 12.69% and ROCE is 13.24%, so profitability is positive, though not exceptional. For anyone following Mankind Pharma Fundamental Analysis, the main takeaway is that the stock combines a strong market value with a valuation that leaves little room for a casual reading of cheapness.

These numbers matter for Mankind Pharma Share Price Today because they place the session decline beside a fuller business picture. The stock is not being read only through price action; it is also being judged through earnings quality, capital efficiency and valuation. That is why Mankind Pharma Stock Analysis often starts with these core ratios rather than only the daily move.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	51.46x
Benchmark Median P/E	32.43x
Benchmark Average P/E	49.46x
Benchmark P/E Range	3.4x to 699.02x
Company P/B Ratio	6.25x
Benchmark Median P/B	2.89x
Benchmark Average P/B	4.38x
Company ROE	12.69%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.68%
Company ROCE	13.24%
Benchmark Median ROCE	13.61%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 1,00,764.41 crore
Benchmark Median Market Cap	Rs 776.09 crore
Benchmark Average Market Cap	Rs 14,255.4 crore

The same-industry benchmark covers 199 companies and gives useful context for Mankind Pharma Share Price. Its P/E of 51.46 is above the industry median of 32.43 and a little above the average of 49.46. The P/B of 6.25 is also above the median of 2.89 and the average of 4.38. ROE at 12.69% is above the benchmark median of 11.7%, while ROCE at 13.24% sits just below the median of 13.61% and close to the average of 13.4%.

The size comparison matters as well. The company’s market capitalisation of Rs 1,00,764.41 crore is far above the industry median market cap of Rs 776.09 crore and above the average of Rs 14,255.4 crore. That scale keeps Mankind Pharma Share Price in focus even when the daily move is only one session long. For Mankind Pharma Share Price Today readers, the sector backdrop suggests a richer valuation profile than many peers, with profitability that is broadly respectable.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,41,477.63	36.9	5.16	14.85	19.11
Divi's Laboratories	DIVISLAB	2,53,031.38	85.99	14.24	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,85,216.32	85.72	20.83	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,20,897.46	26.42	4.42	19.69	21.39
Cipla	CIPLA	1,12,205.15	33.15	3.18	11.83	16

Mankind Pharma Share Price can be read against a peer group that spans a wide valuation range. Sun Pharmaceutical Industries trades at a P/E of 36.9 and P/B of 5.16, Divi’s Laboratories at 85.99 and 14.24, Torrent Pharmaceuticals at 85.72 and 20.83, Zydus Lifesciences at 26.42 and 4.42, and Cipla at 33.15 and 3.18. These peers show that healthcare valuations vary sharply across the industry.

Against that set, Mankind Pharma Share Price carries a higher P/E than Sun Pharma, Zydus Lifesciences, Cipla and Dr. Reddy’s Laboratories, but a lower multiple than Divi’s and Torrent Pharmaceuticals. Its ROE of 12.69% is above Cipla and Dr. Reddy’s, while its ROCE of 13.24% is below Zydus, Divi’s, Torrent and Lupin, but close to Dr. Reddy’s at 13.75%. The comparison suggests that the stock sits in the middle of a broad peer range.

Why Investors Are Watching Mankind Pharma

• Mankind Pharma Share Price fell 2.73% in the latest session, so the day’s move itself is drawing attention.
• The company is a Large Cap with market capitalisation of Rs 1,00,764.41 crore.
• Mankind Pharma Share Price Today trades at a P/E of 51.46, above the industry median.
• ROE of 12.69% and ROCE of 13.24% give a clear profitability reference.
• Mankind Pharma Stock News is being read through sector and peer comparison rather than a verified company-specific trigger.

About Mankind Pharma

Mankind Pharma Share Price belongs to a company in the Healthcare sector and the Pharmaceuticals & Drugs industry. Its available financial data shows EPS of Rs 49.45, book value per share of Rs 407.39 and a dividend yield of 0.04%. That combination points to a business valued more for earnings and scale than for income distribution. For readers tracking Mankind Pharma Stock News, the main context is that the stock is large, established and closely benchmarked within pharma.

Track Mankind Pharma Share Price on Univest

Use Mankind Pharma (MANKIND) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Mankind Pharma Share Price on Univest for live price updates, market capitalisation, key valuation ratios and company insights. Univest also helps readers follow Mankind Pharma Share Price Today, compare it with peers and review the latest healthcare sector context in one place.

Frequently Asked Questions

Why is Mankind Pharma Share Price falling today?

Ans. Mankind Pharma Share Price fell 2.73% to Rs 2,475.50, but the verified data does not establish a company-specific trigger. The move is confirmed as a price fall, so investors are left with price action and valuation context.

What is Mankind Pharma Share Price Today?

Ans. Mankind Pharma Share Price Today is Rs 2,475.50, compared with a previous close of Rs 2,545. The stock opened at Rs 2,545 and moved between Rs 2,460 and Rs 2,554.75 during the session.

What is the market capitalisation of Mankind Pharma?

Ans. Mankind Pharma has a market capitalisation of Rs 1,00,764.41 crore. That places Mankind Pharma Share Price in the Large Cap category and gives the day’s decline a sizeable market-value context.

How is Mankind Pharma valued versus the sector?

Ans. Mankind Pharma Share Price trades at a P/E of 51.46 and P/B of 6.25. Against the same-industry benchmark, both are above the median, which shows the stock is valued richer than many healthcare peers.

What do ROE and ROCE show for Mankind Pharma?

Ans. Mankind Pharma Share Price carries ROE of 12.69% and ROCE of 13.24%. Those numbers show profitability efficiency, with ROE above the industry median and ROCE close to the industry average.

What is EPS and book value for Mankind Pharma?

Ans. EPS for Mankind Pharma is Rs 49.45, while book value per share is Rs 407.39. For Mankind Pharma Share Price, these figures show earnings generated per share and the accounting net worth behind each share.

How does Mankind Pharma compare with peers?

Ans. Mankind Pharma Share Price has a higher P/E than Zydus Lifesciences, Cipla and Dr. Reddy’s, but lower than Divi’s and Torrent. Its ROE and ROCE sit in the mid-range of the peer set.

Should investors track Mankind Pharma Share Price on Univest?

Ans. Yes. Univest lets investors follow Mankind Pharma Share Price Today, valuation ratios, market cap and peer context together. That makes it easier to track the stock’s move alongside sector and company fundamentals.